Daxor Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DX5.F | AVTR | TECN.SW | ALIF-B.ST | SRT.F | BOUL.ST | |
|---|---|---|---|---|---|---|
| Market cap | 42.91M | 10.49B | 3.38B | 22.85B | 15.95B | 47.96M |
| P/E (TTM) | 7.8 | 31.0 | — | 35.6 | 73.1 | — |
| Forward P/E | — | 17.5 | 35.4 | 59.0 | 35.2 | 1.1 |
| Price/book | 0.9 | 1.8 | 3.0 | 3.8 | 5.9 | 0.3 |
| Dividend yield | — | — | 1.23% | 0.81% | 0.32% | — |
| 1-year change | −32.57% | +38.25% | +80.52% | −0.70% | +28.38% | −80.10% |
| Today | 0.00% | −1.09% | +12.18% | +1.63% | +1.32% | +3.78% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.
Latest news
All DX5.F news ›Daxor Corporation (NASDAQ:DXR) Stock Short Interest Falls 51.5%
Posted by Michael Walen on Oct 31st, 2026 Shares of DXR traded up $0.28 during mid-day trading on Friday, reaching $9.20. The company’s stock had a trading volume of 28,009 shares, compared to its average volume of 11,221. Daxor has a…
More from 1 other outlet
Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26
Profusa Receives ISO 13485:2016 Certificate from GMED Daxor (Nasdaq: DXR) will demonstrate its next-generation Blood Volume Analyzer platform at MedAxiom’s CV Transforum in Denver on October 22–24, 2026. The conference takes place at the…
Daxor shares new heart failure data from HFSA 2026 meeting
Daxor Corporation (Nasdaq: DXR) reported clinical study results and clinician engagement following the Heart Failure Society of America 2026 Annual Scientific Meeting, according to a company statement. Researchers from Banner University…
Daxor Announces Strong Commercial Interest and New Clinical Data at HFSA 2026
October 14, 2026 08:00 ET | Source: Daxor Corporation Daxor Corporation New Clinical Studies Validate BVA™ Technology in High-Acuity Heart Failure Populations to Enhance Care OAK RIDGE, TN, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Daxor…
Daxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026
October 13, 2026 08:00 ET | Source: Daxor Corporation Daxor Corporation Making its ASN debut, Daxor’s BVA™ technology delivers precise volume measurement to optimize fluid management and improve complex kidney care. OAK RIDGE, Tenn., Oct.…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- globenewswire.com2
- defenseworld.net1
- stocktitan.net1
- themarketsdaily.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.